<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04711473</url>
  </required_header>
  <id_info>
    <org_study_id>UPCC 13220</org_study_id>
    <secondary_id>843772</secondary_id>
    <nct_id>NCT04711473</nct_id>
  </id_info>
  <brief_title>Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting</brief_title>
  <official_title>Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abramson Cancer Center of the University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Comprehensive Cancer Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Abramson Cancer Center of the University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal&#xD;
      cancer (CRC) screening by outreach to patients' homes using choice architecture informed by&#xD;
      behavioral science principles.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will evaluate the effectiveness of mailed outreach with choice between&#xD;
      colonoscopy and FIT, and FIT alone, as compared to colonoscopy alone in increasing CRC&#xD;
      screening rates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colorectal Cancer Screening Completion</measure>
    <time_frame>6 months from initial outreach</time_frame>
    <description>Screening completion rate in arm 2 (Choice) to arm 1 (Colonoscopy only) and arm 3 (FIT only) separately.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Choice of Colorectal Cancer Screening Test</measure>
    <time_frame>6 months from initial outreach</time_frame>
    <description>The proportion of patients choosing either FIT or Colonoscopy in study arm 2 (Choice)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">903</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Colonoscopy Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this arm will receive a letter from their provider informing them they are overdue for colon cancer screening and requesting their participation in colonoscopy, and including a referral for the procedure at a local endoscopy center. Participants will be provided a phone number if interested in navigated colonoscopy scheduling.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive a letter from their provider informing them they are overdue for colon cancer screening and requesting their participation in their choice of either colonoscopy or mailed fecal immunochemical testing (FIT). The letter will include both a referral for the colonoscopy at a local endoscopy enter and a FIT kit with a lab requisition and instructions for completion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FIT Only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive a letter from their provider informing them they are overdue for colon cancer screening and requesting their participation in FIT testing. The letter will include a FIT kit with lab requisition and instructions for completion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Colonoscopy Only</intervention_name>
    <description>Mailed letter asking participants to complete CRC screening by colonoscopy</description>
    <arm_group_label>Colonoscopy Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Choice</intervention_name>
    <description>Mailed letter and FIT test asking participants to complete CRC screening by their choice of either colonoscopy or mailed FIT</description>
    <arm_group_label>Choice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>FIT Only</intervention_name>
    <description>Mailed letter and FIT test asking participants to complete CRC screening by mailed FIT</description>
    <arm_group_label>FIT Only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. At least 1 visit with CHDC in the past 2 years&#xD;
&#xD;
          2. Not up to date on CRC screening (no evidence of colonoscopy in the last 10 years,&#xD;
             sigmoidoscopy in the last 5 years, or stool testing in the past 12 months)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of CRC or polyps&#xD;
&#xD;
          2. Significant family history of CRC&#xD;
&#xD;
          3. History of Inflammatory Bowel Disease or Ulcerative Colitis&#xD;
&#xD;
          4. History of colectomy&#xD;
&#xD;
          5. History of metastatic cancer&#xD;
&#xD;
          6. Current use of Medication Assisted Therapy (MAT)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shivan Mehta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine Reitz, MPH</last_name>
    <phone>215-614-0282</phone>
    <email>catherine.reitz@pennmedicine.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Community Health and Dental Care</name>
      <address>
        <city>Pottstown</city>
        <state>Pennsylvania</state>
        <zip>19465</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Abramson Cancer Center of the University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Shivan Mehta</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>screening</keyword>
  <keyword>prevention</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>stool testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

